2020
DOI: 10.1536/ihj.19-259
|View full text |Cite
|
Sign up to set email alerts
|

ALDH2 Gene rs671 Polymorphism May Decrease the Risk of Essential Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 18 publications
0
9
0
Order By: Relevance
“…KEGG analysis revealed that the DEGs were involved in several pathways, including the "endocrine system", "cardiovascular diseases", and "neurodegenerative diseases". Hypertension is associated with a reduction in key enzymes that maintain cardiac homeostasis, such as ALDH2 [22][23][24] . However, the ability of these enzymes could be increased by enhanced catalytic activity to counteract the cytotoxic aldehydes produced by lipid peroxidation during hypertension 25 and improved ventricular dysfunction caused by hypertension 26 .…”
Section: Discussionmentioning
confidence: 99%
“…KEGG analysis revealed that the DEGs were involved in several pathways, including the "endocrine system", "cardiovascular diseases", and "neurodegenerative diseases". Hypertension is associated with a reduction in key enzymes that maintain cardiac homeostasis, such as ALDH2 [22][23][24] . However, the ability of these enzymes could be increased by enhanced catalytic activity to counteract the cytotoxic aldehydes produced by lipid peroxidation during hypertension 25 and improved ventricular dysfunction caused by hypertension 26 .…”
Section: Discussionmentioning
confidence: 99%
“…Previously, a link with the cardiovascular disease and hypertension for some of these genes and their protein products was established. Thus, BRAP gene variants were found to be associated with the risk of carotid atherosclerosis (Liao et al, 2011); protein products of genes ATXN2 and SH2B3 were involved in AH development (Siedlinski et al, 2020); rs671 of ALDH2 gene was associated with a decrease in the risk of AH development (Mei et al, 2020). For the variant rs11065987, an association with many pathological conditions was registered, including the level of lipids in blood (Willer et al, 2013), body mass index (Locke et al, 2015), ischemic stroke, ischemic heart disease (Dichgans et al, 2014) and AH (Levy et al, 2009).…”
Section: Assessment Of the Regulatory Potential Of Snps Associated With Arterial Hypertensionmentioning
confidence: 99%
“…On the other hand, the case–control studies indicate that the deficiency of ALDH2 activity affects the risk of cardiovascular and neurodegenerative diseases. Mei et al [ 3 ] showed that the presence of ALDH2* 2/2 (rs67) variant was related to the reduction in the risk of essential hypertension (EH). The authors even put forward the thesis that this variant of ALDH2 could be an attractive candidate for genetic therapy of EH [ 3 ].…”
Section: Commentarymentioning
confidence: 99%
“…Mei et al [ 3 ] showed that the presence of ALDH2* 2/2 (rs67) variant was related to the reduction in the risk of essential hypertension (EH). The authors even put forward the thesis that this variant of ALDH2 could be an attractive candidate for genetic therapy of EH [ 3 ].…”
Section: Commentarymentioning
confidence: 99%